A convenient synthesis of isocyclam and [16]aneN4 and the photophysics of their dicyanochromium(III) complexes

The syntheses of the tetraazamacrocyclic ligands 1,4,7,11-tetraazacyclotetradecane (isocyclam) and 1,5,9,13-tetraazacyclohexadecane ([16]aneN₄) in two steps starting from the corresponding tetraamine and diethylmalonate is reported. The trans-dicyanochromium(III) complexes, trans-[Cr(isocyclam)(CN)₂]PF₆ and trans-[Cr([16]aneN₄)(CN)₂]PF₆ have also been prepared. Both are ²E_g emitters with 0-0 band emission wavelengths at 721.2 and 704.8 nm, respectively. The isocyclam complex has a room temperature excited state lifetime of 147 μs in aqueous solution which increases to 215 μs upon macrocyclic N-H deuteration, whereas the corresponding lifetime of the [16]aneN₄ complex is 25 μs and is unaffected by macrocyclic N-H deuteration. The implications of the temperature dependence of the excited state lifetimes are also presented.     

Copper-thioarylazoimidazole complexes: Structures, photochromism and redox interconversion between Cu(II) ↔ Cu(I) and correlation with DFT calculation

Reaction of Cu(ClO₄)₂·6H₂O, SRaaiNR′ (1-alkyl-2-[(o-thioalkyl)phenylazo]imidazole) and NH₄SCN (1:1:2 mol ratio) affords distorted square pyramidal, [Cu^II(SRaaiNR′)(SCN)₂] (3) compound while identical reaction with [Cu(MeCN)₄](ClO₄) yields -SCN- bridged coordination polymer, [Cu^I(SRaaiNR′)(SCN)]_n (4). These two redox states [Cu^II and Cu^I] are interconvertible; reduction of [Cu^II(SRaaiNR′)(SCN)₂] by ascorbic acid yields [Cu^I(SRaaiNR′)(SCN)]_n while the oxidation of [Cu^I(SRaaiNR′)(SCN)]_n by H₂O₂ in presence of excess NH₄SCN affords [Cu^II(SRaaiNR′)(SCN)₂]. They are structurally confirmed by single crystal X-ray diffraction study. Cyclic voltammogram of the complexes show Cu(II)/Cu(I) redox couple at ∼0.4 V and azo reductions at negative to SCE. UV light irradiation in MeCN solution of [Cu^I(SRaaiNR′)(SCN)]_n (4) show trans-to-cis isomerisation of coordinated azoimidazole. The reverse transformation, cis-to-trans, is very slow with visible light irradiation while the process is thermally accessible. Quantum yields (?_t→c) of trans-to-cis isomerisation are calculated and free ligands show higher ? than their Cu(I) complexes. The activation energy (E_a) of cis-to-trans isomerisation is calculated by controlled temperature experiment. Copper(II) complexes, 3, do not show photochromism. DFT and TDDFT calculation of representative complexes have been used to determine the composition and energy of molecular levels and results have been used to explain the solution spectra, photochromism and redox properties of the complexes.     

Copper(I)-imine complexes: Synthesis and catalytic activity in olefin cyclopropanation

Different imine-type ligands, prepared by the condensation of anilines or of α-methylbenzylamine with 2-pyridinecarboxaldehyde (pyim^1,2) or 2-quinolinecarboxaldehyde (quim^1,2) were prepared. These species act as N,N′-bidentate, chelating ligands upon coordination to Cu(I): treatment of [Cu(PPh₃)₃Cl] with an equimolar amount of the ligands resulted in the displacement of two molecules of PPh₃, giving rise to the formation of [Cu(pyim^1,2)(PPh₃)Cl] (1-2) and [Cu(quim^1,2)(PPh₃)Cl] (3-4), respectively. The copper derivatives 1-4 proved to be highly active catalysts in olefin cyclopropanation in the presence of ethyl diazoacetate, even using deactivated olefins (namely, 2-cyclohexen-1-one) as substrate. The X-ray structure of complex 2, [Cu(pyim²)(PPh₃)Cl], is also reported.     

Simultaneous determination of stable isotopically labelled l-histidine and urocanic acid in human plasma by stable isotope dilution mass spectrometry

A capillary gas chromatographic—mass spectrometric method for the simultaneous determination of stable isotopically labelled l-histidine (l-[3,3-²H₂,1′,3′-¹⁵N₂]histidine, l-His-[M + 4]) and urocanic acid ([3-²H,1′,3′-¹⁵N₂]urocanic acid, UA-[M + 3]) in human plasma was developed using dl-[2,3,3,5′-²H₄,2′-¹³C,1′,3′-¹⁵N₂]histidine (dl-His-[M + 7]) and [2,3,5′-²H₃,2′-¹³C,1′,3′-¹⁵N₂]urocanic acid (UA-[M + 6]) as internal standards. l-Histidine and urocanic acid were derivatized to ^αN-(trifluoroacetyl)-^imN-(ethoxycarbonyl)-l-histidine n-butyl ester and ^imN-(ethoxycarbonyl)urocanic acid n-butyl ester. Quantification was carried out by selected ion monitoring of the molecular ions of the respective derivatives of l-His-[M + 4], dl-His-[M + 7], UA-[M + 3] and UA-[M + 6]. The sensitivity, specificity, precision and accuracy of the method were demonstrated to be satisfactory for measuring plasma concentrations of l-His-[M + 4] and UA-[M + 3] following administration of trace amounts of l-His-[M + 4] to humans.     

Gas chromatographic–mass spectrometric determination of α-ketoisocaproic acid and [2H7]α-ketoisocaproic acid in plasma after derivatization with N-phenyl-1,2-phenylenediamine

A method for determination of α-ketoisocaproic acid (KIC) and [4,5,5,5,6,6,6-²H₇]α-ketoisocaproic acid ([²H₇]KIC) in rat plasma was developed using gas chromatography–mass spectrometry-selected ion monitoring (GC–MS-SIM). [5,5,5-²H₃]α-Ketoisocaproic acid ([²H₃]KIC) was used as an analytical internal standard to account for losses associated with the extraction, derivatization and chromatography. The keto acids were extracted by cation-exchange chromatography using BondElut SCX cartridge and derivatized with N-phenyl-1,2-phenylenediamine to form N-phenylquinoxalinone derivatives. Quantitation was performed by SIM of the respective molecular ions at m/z 278, 281 and 285 for the derivatives of KIC, [²H₃]KIC and [²H₇]KIC on the electron impact method. The limit of detection was found to be 70 fmol per injection (S/N=3) and the limit of quantitation for [²H₇]KIC was around 50 nM in rat plasma. Endogenous KIC concentrations in 50 μl of rat plasma were measured with relative intra- and inter-day precision of 4.0% and 3.3%, respectively. The intra- and inter-day precision for [²H₇]KIC spiked to rat plasma in the range of 0.1 to 10 μM gave good reproducibility with relative standard deviation (RSD) of 6.5% and 5.4%, respectively. The intra- and inter-day relative errors (RE) for [²H₇]KIC were less than 6.4% and 3.8%, respectively. The method was applied to determine the plasma concentration of [²H₇]KIC after an intravenous administration of [²H₇]KIC in rat.     

Copper(II) compounds of the planar-tridentate ligand 2,6-bis(pyrazol-3-yl)pyridine

The tridentate ligand 2,6-bis(pyrazol-3-yl)pyridine (dPzPy) renders coordination compounds with halide, nitrate and tetrafluoroborate salts of copper. The complexes, which have the form [Cu(dPzPy)X₂] with X=Br and Cl, [Cu(dPzPy)(NO₃)₂](H₂O), and [Cu(dPzPy)₂](BF₄)(SiF₆)_0.5(MeOH)₃ have been characterized by elemental analysis and by IR, EPR and ligand field spectroscopy. The single-crystal X-ray structure of [Cu(C₁₁H₉N₅)Br₂] shows the copper(II) ion to be coordinated by three N atoms of 2,6-bis(pyrazol-3-yl)pyridine and two bromides in a geometry exactly in between a trigonal-bipyramid and a square-pyramid. Each molecule lies on a crystallographic C₂-symmetry axis. They are coupled to one another by a two-dimensional network through NH to Br hydrogen bonds. The crystal structure of [Cu(C₁₁H₉N₅)Cl₂] is analogous to the bromide. The single-crystal X-ray structure of [Cu(dPzPy)₂](BF₄)(SiF₆)_0.5(MeOH)₃ shows the copper ion to be in a Jahn-Teller distorted octahedral N₆ environment of two mer-oriented tridentate ligands.     

Reaction of platinum(II) diamine and triamine complexes with selenomethionine

We have reacted [Pt(dien)Cl]Cl, [Pt(en)(D₂O)₂]²⁺, and [Pt(Me₄en)(D₂O)₂]²⁺ [Me₄en = N,N,N′,N′-tetramethylethylenediamine] with selenomethionine (SeMet). When [Pt(dien)Cl]Cl is reacted with SeMet, [Pt(dien)(SeMet-Se)]²⁺ is formed; two Se-CH₃ resonances are observed due to the different chiralities at the Se atom upon platination. In a reaction of [Pt(dien)Cl]Cl with an equimolar mixture of SeMet and Met, the SeMet product forms more quickly though a slow equilibrium with approximately equal amounts of both products is reached. [Pt(Me₄en)(D₂O)₂]²⁺ reacts with SeMet to form [Pt(Me₄en)(SeMet-Se)(D₂O)]²⁺ initially but forms [Pt(Me₄en)(SeMet-Se,N)]⁺ ultimately. One stereoisomer of the chelate, assigned to the R chirality at the Se atom, dominates within the first few minutes of reaction. [Pt(en)(D₂O)₂]²⁺ forms a variety of products depending on reaction stoichiometry; when one equivalent or less of SeMet is added, the dominant product is [Pt(en)(SeMet-Se,N)]⁺. In the presence of excess SeMet, [Pt(en)(SeMet-Se)₂]²⁺ is the dominant initially, but displacement of the en ligand occurs leading to [Pt(SeMet-Se,N)₂] as the eventual product. Displacement of the en ligand from [Pt(en)(SeMet-Se,N)]⁺ does not occur. In reactions of K₂PtCl₄ with two equivalents of SeMet, [Pt(SeMet-Se,N)₂] is formed, and three sets of resonances are observed due to different chiralities at the Se atoms. Only the cis geometric isomers are observed by ¹H and ¹⁹⁵Pt NMR spectroscopy.     

Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand

Copper(I) complexes have been synthesized from the reaction of CuCl, monodentate tertiary phosphines PR₃ (PR₃ = P(C₆H₅)₃; P(C₆H₅)₂(4-C₆H₄COOH); P(C₆H₅)₂(2-C₆H₄COOH); PTA, 1,3,5-triaza-7-phosphaadamantane; P(CH₂OH)₃, tris(hydroxymethyl)phosphine) and lithium bis(3,5-dimethylpyrazolyl)dithioacetate, Li[LCS₂]. Mono-nuclear complexes of the type [LCS₂]Cu[PR₃] have been obtained and characterized by elemental analyses, FT-IR, ESI-MS and multinuclear (¹H, ¹³C and ³¹P) NMR spectral data; in these complexes the ligand behaves as a κ³-N,N,S scorpionate system. One exception to this stoichiometry was observed in the complex [LCS₂]Cu[P(CH₂OH)₃]₂, where two phosphine co-ligands are coordinated to the copper(I) centre. The solid-state X-ray crystal structure of [LCS₂]Cu[P(C₆H₅)₃] has been determined. The [LCS₂]Cu[P(C₆H₅)₃] complex has a pseudo tetrahedral copper site where the bis(3,5-dimethylpyrazolyl)dithioacetate ligand acts as a κ³-N,N,S donor.     

Template synthesis and characterization of hexaaza nickel(II) complex nanoparticles entrapped within the zeolite-Y

Some complexes containing “[Ni([18]py₂N₄)]²⁺, [Ni([20]py₂N₄)]²⁺, [Ni(Bzo₂[18]py₂N₄)]²⁺ and [Ni(Bzo₂[20]py₂N₄)]²⁺” were successfully prepared by the template synthesis of 2,6-diacetylpyridine with [bis(diamine)nickel(II)]; [Ni(N-N)₂]²⁺; within the zeolite-Y. These complexes were entrapped in the supercage of Y-zeolite by a two-step process in the liquid phase: (i) inclusion of a Ni(II) precursor complex, [Ni(diamine)₂]²⁺@NaY, and (ii) template synthesis of the nickel(II) precursor complex with 2,6-diacetylpyridine. The new complex nanoparticles entrapped within the zeolite-Y “[Ni([18]py₂N₄)]²⁺@NaY, [Ni([20]py₂N₄)]²⁺@NaY, [Ni(Bzo₂[18]py₂N₄)]²⁺@NaY, [Ni(Bzo₂[20]py₂N₄)]²⁺@NaY” were characterized by several techniques: chemical analysis and spectroscopic methods (FT-IR, UV-Vis, XRD, BET, DRS). Analysis of the data indicates that the Ni(II) complexes are encapsulated within the zeolite-Y and exhibit different property from those of the free complexes, which can arise from distortions caused by steric effects due to the presence of sodium cations, or from interactions with the zeolite matrix.     

Synthesis, crystal structure and vibrational spectroscopy of a novel mixed ligands Ni(II) pentaborate: [Ni(C4H10N2)(C2H8N2)2][B5O6(OH)4]2

A novel organic-inorganic hybrid pentaborate [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂][B₅O₆(OH)₄]₂ has been synthesized by hydrothermal reaction and characterized by FT-IR, Raman spectroscopy, elemental analyses and DTA-TGA. Its crystal structure was determined from single crystal X-ray diffraction. The structure consists of isolated polyborate anion [B₅O₆(OH)₄]⁻ and nickel complex cation of [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂]²⁺, in which the two kinds of ligands come from the decomposition of triethylenetriamine material. The [B₅O₆(OH)₄]⁻ units are connected to one another through hydrogen bonds, forming a three-dimensional framework with large channel along the a and c axes, in which the templating [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂]²⁺ cations are located. The assignments of the record FT-IR absorption frequencies and Raman shifts were given.     

Cationic copper(I) and silver(I) nitrile complexes with fluorinated weakly coordinating anions: Metal–nitrile bond strength and its influence on the catalytic performance

Copper(I) and silver(I) complexes of formulae [Cu(NCCH₃)₄]⁺[A]⁻ ([A]⁻ = [B(C₆F₅)₄]⁻ (1), {B[C₆H₃(CF₃)₂]₄}⁻ (2), [(C₆F₅)₃B–C₃H₃N₂–B(C₆F₅)₃]⁻ (3), and [Ag(NCCH₃)₄]⁺[B(C₆F₅)₄]⁻ (4) are examined with particular emphasis on the strength of their M–N bond and its influence on the catalytic performance of these complexes in cyclopropanation and aziridination. To examine the strength of the M–N interactions, vibrational spectra of the related hydrogenated and deuterated species [Cu(NCCH₃)₄]⁺, [Cu(NCCD₃)₄]⁺, [Ag(NCCH₃)₄]⁺, and [Ag(NCCD₃)₄]⁺ are also determined. It is found that the metal–nitrile bond strength is an important factor for the catalytic activity of the respective complexes.     

Synthesis of tantalum and niobium complexes that contain the diamidoamine ligand, [(3,4,5-F3C6H2NCH2CH2)2NMe], and the triamidoamine ligand, [(3,5-Cl2C6H3NCH2CH2)3N]

Several niobium and tantalum compounds were prepared that contain either the diamidoamine ligand, [(3,4,5-F₃C₆H₂NCH₂CH₂)₂NMe]²⁻ ([F₃N₂NMe]²⁻), or the triamidoamine ligand, [(3,5-Cl₂C₆H₃NCH₂CH₂)₃N]³⁻ ([Cl₂N₂NMe]³⁻). The former include [F₃N₂NMe]TaCl₃, [F₃N₂NMe]NbCl₃, [F₃N₂NMe]TaMe₃, [F₃N₂NMe]NbMe₃, [(F₃N₂NMe)TaMe₂][MeB(C₆F₅)₃], [F₃N₂NMe]Ta(CHSiMe₃)(CH₂SiMe₃), [F₃N₂NMe]Ta(CH₂-t-Bu)Cl₂, [F₃N₂NMe]Ta(CH-t-Bu)(CH₃), and [F₃N₂NMe]Ta(η²-C₂H₄)(CH₂CH₃). The latter include [Cl₂N₂NMe]TaCl₂, [Cl₂N₂NMe]TaMe₂, [Cl₂N₂NMe]Ta(η²-C₂H₄), and [Cl₂N₂NMe]Ta(η²-C₂H₂).X-ray diffraction studies were carried out on [F₃N₂NMe]Ta(CHSiMe₃)(CH₂SiMe₃), [F₃N₂NMe]Ta(η²-C₂H₄)(CH₂CH₃), and [Cl₂N₂NMe]TaMe_2..     

Synthesis, structural characterization and redox properties of copper(II) and manganese(II) complexes containing tridentate (N-(2-methylpyridine)-2-aminomethyl benzoate) ligand

Two new complexes, [Cu(mamba)₂] and [Mn(mamba)₂] (mamba⁻, N-(2-methylpyridine)-2-aminomethyl benzoate) were synthesized and characterized by X-ray crystallography. Whereas the [Cu(mamba)₂] complex crystallizes in a monoclinic P2₁/c space group, the [Mn(mamba)₂] complex crystallizes in a triclinic space group. The nature of the metal ion greatly influences the lattices and the molecular structures of the compounds. In the crystal lattice of the copper complex are four cocrystallized methanol solvent, which are all involved in building six strong H-bonds with the complex. However, the lattice for the manganese complex contain only one cocrystallized methanol, along with one NaClO₄, that is also involved in making one H-bond with the [Mn(mamba)₂] unit. Nevertheless, the sodium ion is coordinated to the ClO₄⁻, the methanol and two [Mn(mamba)₂] to form a stable extended chain metal complex. Electrochemical studies indicated that both complexes undergo quasi reversible one electron reduction in acetonitrile.     

The mononuclear–dinuclear dance: Twisting the backbone in metalloligands operates a coordination switch

The copper(II) complex [Cu{(R,R)-1}] in which (R)-H₂1 is 1,6-bis(3-ethoxy-2-hydroxyphenyl)-(3R,4R)-(?)-cyclohexane-1,2-diyl-2,5-diazahexa-1,5-diene possesses an O₄-donor cavity that can bind Pb²⁺, Cd²⁺ and Eu³⁺. The single crystal structures of [Cu(OH₂){(R,R)-1}Pb(ONO₂)₂], {[Cu{(R,R)-1}Cd(ONO₂)(OH₂)₂][NO₃]^.MeOH}^.[Cu{(R,R)-1}] and [Cu{(R,R)-1}Eu(O₂NO)₃] are presented. The co-crystallization of [Cu{(R,R)-1}Cd(ONO₂)(OH₂)₂][NO₃] and [Cu{(R,R)-1}] appears to be driven by hydrogen-bonded host–guest interactions between each axial water ligand in [Cu{(R,R)-1}Cd(ONO₂)(OH₂)₂]⁺ with the O₄-domain of [Cu{(R,R)-1}]. When the ligand scaffold is changed from cyclohexane-1,2-diyl to 1,1′-binaphthyl to give (R)-H₂2, the N₂O₂-cavity is unable to bind copper(II) in its preferred square planar environment. The single crystal structure of [Zn{(R)-2}] confirms the presence of tetrahedral zinc(II). As a result, the spatial properties of the ethoxy arms in [Zn{(R)-2}] and [Cu{(R)-2}] are not suited to the facile formation of dimetallic complexes.     

A novel one-dimensional acentric copper(I) coordination polymer with second-harmonic generation response

The reaction of N,N-(2-pyridyl)(4-pyridylmethyl)amine with [Cu(MeCN)₂(PPh₃)₂]ClO₄ in the presence of THF affords a novel one-dimensional copper(I) coordination polymer {[Cu(PPh₃)(N,N-(2-pyridyl)(4-pyridylmethyl)amine)](ClO₄)}_n (1), which crystallizes in an noncentrosymmetric space group and displays strong second-harmonic generation (SHG) response.     

Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules

Piroxicam H₂PIR (H₂PIR, 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide), [Cu(HPIR)₂(H₂O)₂] previously prepared and tested from this laboratory and at National Institute of Health, National Cancer Institute, Developmental Therapeutic Program, NIH-NCI-DTP, USA [R. Cini, G. Tamasi, S. Defazio, M.B. Hursthouse, J. Inorg. Biochem. 101 (2007) 1140-1152, and references cited therein], [Cu(HMEL)₂(DMF)] (H₂MEL, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; DMF, N,N-dimethylformamide), [Cu(HISO)₂] (H₂ISO, 4-hydroxy-2-methyl-N-(5-methylisoxazol-3-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide), and [Cu(HTEN)₂(H₂O)₂] (H₂TEN, 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide), were loaded on CMH2 hydrogel (co-1:10-poly(N-methacryloyl-l-histidine-co-N-isopropylacrylamide) cross-linked with N,N′-ethylene-bis-acrylamide (EBA) 2%) and the kinetics of release of Cu-HPIR species in several media were studied. The release of Cu(HPIR)₂ in DMSO from CMH2 hydrogel after swelling and loading from DMSO followed a diffusion controlled process. The release of Cu(HPIR)/Cu(HPIR)₂ from dried CMH2 hydrogel after swelling and loading from THF solution, then soaking into water/DMSO 95:5 v/v (pH 5.6) followed a relaxation controlled and diffusion controlled mechanism. The amount of Cu(HPIR)₂ released in the medium reached 0.03 μg Cu/mg gel/mL, i.e. ca 0.8 μM within 48 h that compares well with the IC₅₀ values reported for metal based drugs like carboplatin (diammino(1,1-cyclobutandicarboxylato)platinum(II)) against certain human tumor cell lines. The release studies performed by monitoring both the absorbance values at 362 nm (sensitive to metal-bound HPIR⁻) and the content of Cu via AAS, showed an excellent agreement with the Cu(HPIR)₂ or Cu(HPIR)₂ stoichiometry, depending on the delivery medium. Corresponding studies were performed for other Cu(oxicam-H)₂ species in different delivery media.     

Synthesis of carbon-11-labeled CK1 inhibitors as new potential PET radiotracers for imaging of Alzheimer’s disease

The reference standards methyl 3-((2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)carbamoyl)benzoate (5a) and N-(2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)-3-methoxybenzamide (5c), and their corresponding desmethylated precursors 3-((2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)carbamoyl)benzoic acid (6a) and N-(2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)-3-hydroxybenzamide (6b), were synthesized from 5-amino-2,2-difluoro-1,3-benzodioxole and 3-substituted benzoic acids in 5 and 6 steps with 33% and 11%, 30% and 7% overall chemical yield, respectively. Carbon-11-labeled casein kinase 1 (CK1) inhibitors, [¹¹C]methyl 3-((2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)carbamoyl)benzoate ([¹¹C]5a) and N-(2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)-3-[¹¹C]methoxybenzamide ([¹¹C]5c), were prepared from their O-desmethylated precursor 6a or 6b with [¹¹C]CH₃OTf through O-[¹¹C]methylation and isolated by HPLC combined with SPE in 40–45% radiochemical yield, based on [¹¹C]CO₂ and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the molar activity (MA) at EOB was 370–740?GBq/μmol with a total synthesis time of ～40-min from EOB.     

Synthesis and coordination behaviors of 14-membered tetraaza macrocyclic copper(II) complexes bearing two N-propionic acid or N-propionic methyl ester groups

A di-N-functionalized 14-membered tetraaza macrocycle, [H₄L³](ClO₄)₂ (L³ = 1,8-bis(2-carboxyethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane), has been synthesized by acid hydrolysis of 1,8-bis(2-cyanoethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane (L²). The copper(II) complexes [CuL²](ClO₄)₂ and [Cu(H₂L³)](ClO₄)₂ were prepared and characterized. The complex [Cu(H₂L³)]²⁺ readily reacts with methanol to yield [CuL⁴]²⁺ (L⁴ = 1,8-bis(2-carbomethoxyethyl)-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane). The N-CH₂CH₂COOH groups of [Cu(H₂L³)](ClO₄)₂ are not coordinated to the metal ion in the solid state but are involved in coordination in various non-aqueous solvents or in aqueous solutions of pH ? 1.0. Interestingly, [CuL⁴](ClO₄)₂ exists as two stable structural isomers, 1 (the pendant ester groups are not involved in coordination) and 2 (one of the two ester groups is coordinated to the metal ion), in the solid state; the two isomers can be prepared selectively by controlling ionic strength of a methanol solution of the complex. Crystal structures and coordination behaviors of the two isomers are described. The di-N-cyanoethylated macrocyclic complex [CuL²](ClO₄)₂ is rapidly decomposed in 0.1 M NaOH solution even at room temperature. On the other hand, [Cu(H₂L³)](ClO₄)₂ and [CuL⁴](ClO₄)₂ are quite inert against decomposition under similar basic conditions. In acidic or basic aqueous solutions, [CuL⁴]²⁺ is hydrolyzed to [Cu(H₂L³)]²⁺ or [CuL³].     

Copper(II) PMDTA and copper(II) TMEDA complexes: precursors for the synthesis of dinuclear dicationic copper(II) complexes

Copper(II) cations coordinated with PMDTA (pentamethyldiethylenetriamine) and TMEDA (tetramethylethylenediamine) possess a high synthetic potential. The synthesis of these cations was carried out by metathesis reactions with silver salts. The cationic copper(II) complexes, [Cu(PMDTA)(Me₂CO)Cl]⁺, [Cu(PMDTA)(H₂O)Cl]⁺, [Cu(PMDTA)(DMF)]⁺, [Cu(PMDTA)Cl]⁺, [Cu(PMDTA)OAc]⁺, [Cu(PMDTA)(MeCN)₂]²⁺, [Cu₂(TMEDA)₂Cl₃]⁺ and [Cu(TMEDA)(MeCN)₃]²⁺ were synthesised as PF₆ salts, crystallised and characterised by single-crystal X-ray diffraction.     

Silver(I) derivatives with new functionalised acylpyrazolonates

Silver(I) acylpyrazolonate derivatives of formula [Ag(Q)(R₃P)]₂ and [Ag(Q)(R₃P)₂], (QH=1-phenyl-3-methyl-4-R′(CO)-pyrazol-5-one; Q^OH, R′=furane; Q^SH, R′=thiophene; R=Ph, Cy, o-tol), have been synthesised and characterised, both in the solid state and in solution. The derivatives [Ag(Q)(R₃P)]₂ contain dinuclear AgO₂NP units with the acylpyrazolonate coordinating in a bridging O,O′-Q-N fashion. The [Ag(Q)(R₃P)₂] are tetrahedral species, with the distortion from ideal geometry increasing with the bulk of the phosphine. The [Ag(Q)(R₃P)₂] derivatives are fluxional in chloroform solution when R₃P is sterically hindered (R=Cy or o-tol), dissociating partially to the [Ag(Q)(R₃P)] fragment and free R₃P. [Ag(Q^S)(Ph₃P)]₂ reacts with 1-methyl-2-mercaptoimidazole (Hmimt) affording the compound [Ag(Hmimt)(Ph₃P)(Q^S)] and [Ag(Q^O)(Ph₃P)]₂ reacts with 1-methyl-imidazole (Meim) affording the compound [Ag(Meim)(Ph₃P)(Q^O)], whereas [Ag(Q^S)(Ph₃P)]₂ reacts with 1,10-phenanthroline (phen), affording the compound [Ag(phen)(Ph₃P)](Q^S). Finally [Ag(Q^S)(Ph₃P)₂] reacts with phen producing the ionic species [Ag(phen)(Ph₃P)₂](Q^S).